Merck & Co., Inc. (MRK)

NYSE

$147,45

$-3,65

(-2,42%)

Regular Market

Merck & Co., Inc. (MRK) Live Price Chart

Last updated: ⁦2026-09-23 17:24:40⁩. Prices reflect the latest regular market data. Stock price data is sourced from Massive.

Summary

Merck & Co., Inc. (MRK) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NYSE. The stock is currently priced at $147,45, with a market capitalisation of $368,84B and a P/E ratio of 117,34. Over the past 52 weeks, its price has ranged from $77,58 to $156,92. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$368,84B
Open	$151,32
Day's High	$156,92
Day's Low	$15,32
Previous Close	$150,91
Volume	4,04M
Average Volume	10,17M
P/E Ratio	117,34
52-Week High	$156,92
52-Week Low	$77,58
Dividend Yield	2,23%
Earnings Date	--

Merck & Co., Inc. (MRK) Stock Price Today

Merck & Co., Inc. (MRK) is currently trading at $147,45 as of 2026-09-23 17:08:51, down 2,29% ($3,46) from the previous close of $150,91

During today's regular trading session, MRK has traded between $15,32 and $156,92, with a trading volume of 4,04M shares. The current price is near the upper end of today's range.

Merck & Co., Inc. (MRK) 7-Day Stock Price Change

Over the past seven days, Merck & Co., Inc. (MRK) moved from $144,85 to $147,45, representing a gain of 1,79% ($2,60).

The stock traded between $142,32 and $153,57 during the period. The latest price is near the middle of the 7-day range, indicating moderate upward.

The average daily volume was 12,05 million shares, up versus the previous seven-day period, indicating higher trading activity.

MRK 52-Week Price Position

Position in Range: 88,1%

52W Low$77,58

52W High$156,92

MRK is currently trading at $147,45, placing it 88,1% of the way from its 52-week low of $77,58 to its 52-week high of $156,92. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Merck & Co., Inc. (MRK)?

Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. In cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor to overall sales. The company also has a substantial vaccine business aimed at preventing pediatric diseases, as well as Gardasil for human papillomavirus. Additionally, Merck sells animal health-related drugs. From a geographical perspective, 53% of the company's 2025 sales were generated from US human health (pharmaceuticals and vaccines).

Merck & Co., Inc. Information

Industry	PHARMACEUTICAL PREPARATIONS
Employees	75000
Exchange	NYSE
Company Website	https://www.merck.com

How to Buy Merck & Co., Inc. (MRK) Stock on MEXC

Eligible investors can buy real shares of Merck & Co., Inc. (MRK) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licenced broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for MRK and Place Your Order

Open the RealStocks trading page and search for MRK. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Merck & Co., Inc. (MRK) stock price today?

Merck & Co., Inc. (MRK) is currently trading at $ 147,45, down 2,29% ($3,46) from the previous close of $ 150,91. Intraday prices update in real time during regular trading hours.

2.Is MRK stock going up or down today?

As of 2026-09-23 17:08:51, MRK is trading at $ 147,45, down 2,29% ($3,46) from its previous close of $ 150,91. The stock has traded between $ 15,32 and $ 156,92 during today’s regular session. Past price movements do not guarantee future results.

3.What is MRK pre-market price?

As of 2026-09-23 17:08:51, MRK is trading at $ 150,72 in pre-market trading, down 0,13% ($0,19) from the previous close of $ 150,91. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is MRK after-hours price?

As of 2026-09-23 17:08:51, MRK is trading at $ 150,94 in after-hours trading, up 0,02% ($0,03) from the regular-session close of $ 150,91. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is MRK stock trading now?

MRK trades on the NYSE exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does MRK sit relative to its 52-week high and low?

Over the past 52 weeks, MRK has traded between a low of $ 77,58 and a high of $ 156,92. At $ 147,45, the stock is positioned 88,1% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Merck & Co., Inc. in?

Merck & Co., Inc. (MRK) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Merck & Co., Inc.'s market capitalisation and where is it listed?

Merck & Co., Inc. is listed on the NYSE exchange with a market capitalisation of $ 368,84B. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is MRK valued in terms of P/E ratio and EPS?

MRK trades at a P/E ratio of 117,34, based on trailing-twelve-month EPS of $ 1,29. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Merck & Co., Inc. pay a dividend?

Merck & Co., Inc. pays an indicated annual cash dividend of $ 3,29 per share, with a current dividend yield of 2,23% based on the latest share price. Dividend policies are subject to change at the board's discretion.